Search

everythinglearnresearchcommunity

for

Search:↓

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Eating junk food is linked to higher rates of PCOS and related symptoms in women.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

PCOS requires personalized treatment to improve life quality and reduce health risks.

EZH2 levels decrease as fetuses develop and are higher in adult skin, which may affect skin growth and repair.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

These ovarian conditions cause high testosterone levels.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Young women with PCOS without additional risk factors may have normal heart function.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Lupus patients' body image issues significantly affect their mental health and need more support.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.